Navigation Links
Low-dose Omega-3 Linked to Lower Blood Pressure

Low doses of the omega-3 fatty acids docosahexaenoic acid (DHA) successfully reduced diastolic blood pressure by 3.3 mmHg in a clinical trial, backing up previous results with higher doses. //

"A significant reduction in diastolic BP was noted which is likely to be of clinical significance with regard to risk of future vascular events in middle-aged subjects," wrote lead author Hannah Theobald from King's College London.

Omega-3 has been identified as one of the super-nutrients taking the food and supplements industry by storm. Much of its healthy reputation that is seeping into consumer consciousness is based largely on evidence that it can aid cognitive function and may help protect the heart against cardiovascular disease.

Several intervention trials have reported positive benefits on blood pressure and cardiovascular disease using omega-3 fatty acids. Indeed, Theobald noted that a meta-analysis of randomized, controlled trials showed significant decreases in both systolic and diastolic blood pressure with omega-3 doses in the region of two to three grams per day.

To test if lower doses also conferred a positive effect, the King's College researchers recruited 38 middle-aged subjects (average age 48.6, average BMI 24 kg per sq.m, baseline average blood pressure 121.6/79.15 mmHg) to randomly receive either a 0.7 gram daily dose of DHA derived from Crypthecodinium cohnii (Martek Biosciences) or an olive oil placebo for three months. A four-month washout period separated the cross-over to the alternative intervention.

Writing in the current issue of the Journal of Nutrition Theobald states that the daily DHA supplement increased DHA levels in red blood cells (erythrocytes) by 58 per cent. Diastolic blood pressure decreased by an average of 3.3 mmHg, while no significant differences occurred for systolic blood pressure, she said.

Other measures of cardiovascular function, like the markers o f inflammation, C-reactive protein and interleukin-6 (IL-6), were not affected significantly by supplemental DHA.

The potential mechanism behind these effects was not studied directly, but the researchers state that other studies have proposed a direct effect of the omega-3 fatty acids on the electrophysiology of the heart by affecting the sinus node (the heart's natural pacemaker) or efficiency of the ventricles.

"Future work is needed to confirm these findings and to investigate further the effects of DHA on cardiac function," concluded the researchers.

Hypertension, defined as having a systolic and diastolic BP greater than 140 and 90 mmHg, affects about 600 million people worldwide and is associated with over seven million deaths.

Commenting independently on the study, June Davidson, a cardiac nurse from UK charity, the British Heart Foundation (BHF) told NutraIngredients.com: "This study shows that low dose supplements with long chain omega-3 can lower diastolic blood pressure. However we need further research to show whether such low doses could reduce cardiovascular events, such as heart attacks or strokes.

"Diets rich in long chain omega-3 fats are beneficial for heart health. The best source of these omega -3s is oily fish, such as mackerel, sardines, salmon, trout and fresh tuna."

Source-Bio-Bio Technology
'"/>




Related medicine news :

1. Low-dose Growth Hormone (GH) with diet and exercise may help weight loss
2. Low-dose Aspirin Benefits Both Sexes
3. Low-dose Aspirin Beats High-dose After Cardiac Surgery
4. Clinical Trials for a Low-dose Steroid Therapy for Bone Marrow Cancer Prove Positive
5. Omega-3 fatty acids impair immunity
6. An Omega-3 and Omega-6 Diet Could Enhance Breast Cancer Treatment
7. Consume Omega-3s &d Omega –6s and Prevent Osteoporosis
8. Another Benefit For Human Health Attributed To Omega-3-Fats
9. Omega-3 May Help Special Children
10. A Diet Rich in Omega-3 Has Numerous Health Benefits
11. Proper Ratio Of Omega-3 And Omega-6 Could Reduce Prostate Cancer Growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... ... May 02, 2016 , ... Dr. Jonathan Kulbersh of Carolina Facial Plastics isn’t surprised ... five on the list of “ 5 US Cities with the Highest Plastic Rates .” ... and Miami. The results were calculated using a survey by RealSelf and ...
(Date:5/2/2016)... ... May 02, 2016 , ... MedaCheck, a leading medication ... outcomes, has announced its partnership with GrandView Health Services. , With decades of ... counter and prescription drug pharmacy services to thousands of residents. Serving Indiana, Ohio, ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Evolve Paddle Board Company- which specializes ... today the outcome of their partnership with Yoloha Yoga- producers of high quality cork ... , SUP yoga has seen a dramatic rise in popularity throughout the last few ...
(Date:5/2/2016)... ... May 02, 2016 , ... One of Hollywood’s best kept ... Dermatology Surgery & Laser Center, in Milford, Penn. “Patients with busy lives want noninvasive ... fat treated and go home or back to work without having to wear recovery ...
(Date:5/2/2016)... Worcester, MA and Shelton, CT (PRWEB) , ... May 02, 2016 ... ... Scott Krug, President and Owner of New England Low Vision and Blindness (NELV&B) ... location will add more flexibility and convenience for people with vision impairments to get ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016 , Net Sales of $1.90 ... over the prior year period, and an increase of 1.2% ... Diluted EPS for the first quarter were $0.52 reported, a ... adjusted, an increase of 29.9% over the prior year period ... earnings guidance for 2016 Zimmer Biomet Holdings, Inc. ...
(Date:4/28/2016)... Florida , April 28, 2016 ... the development of innovative peptide and gene-based immunotherapeutics and vaccines ... it will be presenting at the 3rd Annual Growth ... - 5 th , 2016 at Caesars Palace in Las Vegas, ... 8.00 am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: